SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-14-053216
Filing Date
2014-08-29
Accepted
2014-08-29 10:19:39
Documents
5
Effectiveness Date
2014-08-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A v388102_defa14a.htm DEFA14A 29359
2 GRAPHIC image_005.jpg GRAPHIC 720
3 GRAPHIC image_006.jpg GRAPHIC 995
4 GRAPHIC image_007.jpg GRAPHIC 861
5 GRAPHIC image_008.jpg GRAPHIC 799
  Complete submission text file 0001144204-14-053216.txt   35916
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFA14A | Act: 34 | File No.: 000-17263 | Film No.: 141073653
SIC: 2836 Biological Products, (No Diagnostic Substances)